TEST BANK FOR INTRODUCTORY CLINICAL
pp pp pp pp
pp PHARMACOLOGY 12TH EDITION BY SUSAN FORD
pp pp pp pp pp
CHAPTER 1-54 | COMPLETE GUIDE
pp pp pp pp pp
, Chapter 01: General Principles of Pharmacology
pp pp pp pp pp
Ford: Introductory Clinical Pharmacology 12th Edition
pp pp pp pp pp
1. Afterppteachingppa ppgroup ppofpplearnersppaboutpptheppbasicsppofpppharmacology, ppthe pplearners ppwill
ppbe ppable ppto ppchoose ppwhich ppaspect ppas ppthe ppmost ppcritical ppto ppremember?
A) Drug ppname
B) Drug ppclass
C) Drug ppaction
D) Drug ppsource
ACCURATE ppCHOICE:-C
Reasoning pp:->> ppPharmacology ppis ppthe ppstudy ppof ppdrugs ppand ppits ppaction ppon ppliving
pporganisms. ppThus, ppan ppessential ppaspect ppof pppharmacology ppis ppdrug ppaction. ppAn
ppunderstanding ppof ppthe ppdrug ppname, ppdrug ppclass, ppand ppdrug ppsource ppis ppimportant, ppbut
ppthe ppmost p p critical ppaspect pprelated ppto pppharmacology ppis pphow ppthe ppdrug ppacts ppin ppthe
ppbody.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp1 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppPhysiological ppIntegrity: ppPharmacological
ppTherapies ppIntegrated ppProcess: ppTeaching/Learning
Reference: ppp. pp3, ppIntroduction
2. A ppnursing ppattendant ppsuspects ppthe pphospital ppclient pphad ppan ppadverse ppreaction ppto ppa
ppprescribed ppmedication ppdue ppto ppan ppinteraction ppwith ppan ppunreported ppover-the-
counter ppsupplement. ppWhich ppaction ppby ppthe ppnursing ppattendant ppwill ppbest ppassist ppin
pppreventing ppfuture ppsimilar ppincidents?
A) File ppa ppreport ppwith ppMedWatch
B) File ppa ppreport ppwith ppthe ppState ppBoard ppof ppNursing
C) Instruct ppthe pphospital ppclient ppto ppavoid ppcombining ppmedications ppin ppthe ppfuture
D) Document ppthe ppincident pp and ppreport ppit ppto ppthe ppprimary pphealth ppcare ppprovider
ACCURATE ppCHOICE:-A
Reasoning pp:->> ppProfessional ppnurses ppplay ppan ppimportant pprole ppin ppmonitoring ppfor
ppadverse ppreactions. ppTherefore, ppit ppis ppimportant ppto ppsubmit ppreports, ppeven ppif ppthere ppis
ppuncertainty ppabout ppthe ppcause–effect pprelationship. ppThe ppFDA ppprotects ppthe ppidentity ppof
ppthose ppwho ppvoluntarily ppreport ppadverse ppreactions.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp9 ppCognitive
ppLevel: ppApply
, Hospital ppclient ppNeeds: ppSafe ppand ppEffective ppCare ppEnvironment: ppSafety ppand ppInfection
ppControl
Integrated ppProcess: ppClinical ppProblem-solving ppProcess pp(Nursing ppProcess)
ppReference: ppp. pp7, ppBox pp1.1 ppMedWatch ppand ppReporting ppAdverse
ppEvents
3. A ppnursing ppattendant ppis ppassessing ppa pphospital ppclient ppand ppnotes ppthe pphospital ppclient
pphas ppdeveloped ppswelling ppof ppthe ppeyelids ppand pplips ppafter ppadministration ppof ppa
ppprescribed ppmedication. ppWhat ppdoes ppthe ppnursing ppattendant ppinterpret ppthis ppfinding ppto
ppspecifically ppindicate?
A) Mild ppallergic ppreaction
B) Anaphylactic ppshock
C) Angioedema
D) Drug ppidiosyncrasy
ACCURATE ppCHOICE:-C
Reasoning:->> ppAngioedema ppis ppa pptype ppof ppallergic ppdrug ppreaction ppmanifested ppby ppthe
ppcollection ppof ppfluid ppin ppthe ppsubcutaneous pptissues, ppmost ppcommonly ppaffecting ppthe
ppeyelids, pplips, ppmouth, ppand ppthroat. ppAllergic ppreactions ppcan ppbe ppmanifested ppby ppa ppwide
pprange ppof ppsigns ppand ppsymptoms ppsuch ppas ppitching, pprashes, ppand pphives. ppAnaphylactic
ppshock ppis ppa ppserious ppallergic ppreaction ppthat pprequires ppimmediate ppmedical ppattention.
ppDrug ppidiosyncrasy ppdescribes ppany ppunusual ppor ppabnormal ppreaction ppto ppa ppdrug, ppone ppthat
ppis ppdifferent ppfrom ppthe ppone ppnormally ppexpected.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp5 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppPhysiological ppIntegrity: ppReduction ppof ppRisk
ppPotential ppIntegrated ppProcess: ppClinical ppProblem-solving ppProcess pp(Nursing
ppProcess) ppReference: ppp. pp12, ppAllergic ppDrug ppReactions
4. The ppnursing ppattendant ppis pppreparing ppto ppteach ppa pphospital ppclient ppabout ppa ppnew ppdrug
ppwhich ppis ppin ppthe ppfourth ppphase ppof ppdevelopment. ppWhich ppactivity ppwill ppthe ppnursing
ppattendant ppexplain ppbest ppillustrates ppthis ppphase?
A) Primary pphealth ppcare ppproviders ppreport ppadverse ppeffects ppto ppFDA.
B) Healthy ppvolunteers ppare ppinvolved ppin ppthe pptest.
C) In ppvitro pptests ppare ppperformed ppusing pphuman ppcells.
D) The ppdrug ppis ppgiven ppto pp hospital ppclients ppwith ppthe ppdisease.
ACCURATE ppCHOICE:-A
, Reasoning:->> ppThe pppost ppmarketing ppsurveillance ppphase ppof ppdrug ppdevelopment
ppencourages ppprimary pphealth ppcare ppprofessionals ppto ppreport ppadverse ppeffects ppof ppdrugs ppto ppthe
ppFDA ppusing ppMedWatch. ppPhase pp1 ppof ppclinical pptesting ppinvolves pp20 ppto pp100 pphealthy
ppvolunteers. ppIn ppvitro pptesting ppof ppthe ppdrug ppon pphuman ppor ppanimal ppcells ppis ppdone ppin ppthe
pppre-FDA ppphase. ppIn ppPhase pp2 ppof ppclinical pptesting, ppthe ppdrug ppis ppgiven ppto pphospital
ppclients ppwith ppthe ppdisease ppfor ppwhich ppthe ppdrug ppis ppmanufactured.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp4 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppHealth ppPromotion ppand
ppMaintenance ppIntegrated ppProcess: ppTeaching/Learning
ppReference: ppp. pp7, ppConcept ppMastery ppAlert
5. A ppnursing ppattendant ppis ppassessing ppan ppexpectant pphospital ppclient ppwho ppadmits ppto
pphaving ppa ppcocaine ppaddiction. ppWhich ppcondition ppof ppthe ppbaby ppafter ppbirth
ppshould ppthe ppnursing ppattendant ppexplain ppand ppprepare ppthe pphospital ppclient ppfor?
A) Diabetes
B) Hypertension
C) Addiction ppto ppdrugs
D) CNS ppdefects
ACCURATE ppCHOICE:-C
Reasoning:->> ppThe ppnursing ppattendant ppinforms ppthe pphospital ppclient ppthat ppchildren
ppborn ppto p p mothers ppusing ppaddictive ppdrugs ppare ppoften ppborn ppwith ppan ppaddiction ppto
ppthe ppdrug. ppChildren ppborn ppto ppmothers ppwho ppare ppaddicted ppto ppcocaine ppare ppnot
ppknown ppto ppbe ppborn ppwith ppdiabetes, ppCNS ppdefects, ppor pphypertension.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp6 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppHealth ppPromotion ppand
ppMaintenance ppIntegrated ppProcess: ppTeaching/Learning
Reference: ppp. pp11, ppDrug ppUse, ppPregnancy, ppand ppLactation
6. A pphospital ppclient pparrives ppat ppthe ppprimary pphealth ppcare ppclinic ppand ppreports pptaking
ppseveral pppills ppfor ppa ppheadacheppand ppsevere ppcough ppwithout pprelief. ppWhich ppadverse
ppeffect ppshould ppthe ppnursing ppattendant ppbe ppaware ppmay ppdevelop ppfrom ppthis
ppcombination?
A) Gastrointestinal ppbleeding
B) Breathing ppdifficulties
C) Liver ppdamage
D) Anaphylaxis
pp pp pp pp
pp PHARMACOLOGY 12TH EDITION BY SUSAN FORD
pp pp pp pp pp
CHAPTER 1-54 | COMPLETE GUIDE
pp pp pp pp pp
, Chapter 01: General Principles of Pharmacology
pp pp pp pp pp
Ford: Introductory Clinical Pharmacology 12th Edition
pp pp pp pp pp
1. Afterppteachingppa ppgroup ppofpplearnersppaboutpptheppbasicsppofpppharmacology, ppthe pplearners ppwill
ppbe ppable ppto ppchoose ppwhich ppaspect ppas ppthe ppmost ppcritical ppto ppremember?
A) Drug ppname
B) Drug ppclass
C) Drug ppaction
D) Drug ppsource
ACCURATE ppCHOICE:-C
Reasoning pp:->> ppPharmacology ppis ppthe ppstudy ppof ppdrugs ppand ppits ppaction ppon ppliving
pporganisms. ppThus, ppan ppessential ppaspect ppof pppharmacology ppis ppdrug ppaction. ppAn
ppunderstanding ppof ppthe ppdrug ppname, ppdrug ppclass, ppand ppdrug ppsource ppis ppimportant, ppbut
ppthe ppmost p p critical ppaspect pprelated ppto pppharmacology ppis pphow ppthe ppdrug ppacts ppin ppthe
ppbody.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp1 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppPhysiological ppIntegrity: ppPharmacological
ppTherapies ppIntegrated ppProcess: ppTeaching/Learning
Reference: ppp. pp3, ppIntroduction
2. A ppnursing ppattendant ppsuspects ppthe pphospital ppclient pphad ppan ppadverse ppreaction ppto ppa
ppprescribed ppmedication ppdue ppto ppan ppinteraction ppwith ppan ppunreported ppover-the-
counter ppsupplement. ppWhich ppaction ppby ppthe ppnursing ppattendant ppwill ppbest ppassist ppin
pppreventing ppfuture ppsimilar ppincidents?
A) File ppa ppreport ppwith ppMedWatch
B) File ppa ppreport ppwith ppthe ppState ppBoard ppof ppNursing
C) Instruct ppthe pphospital ppclient ppto ppavoid ppcombining ppmedications ppin ppthe ppfuture
D) Document ppthe ppincident pp and ppreport ppit ppto ppthe ppprimary pphealth ppcare ppprovider
ACCURATE ppCHOICE:-A
Reasoning pp:->> ppProfessional ppnurses ppplay ppan ppimportant pprole ppin ppmonitoring ppfor
ppadverse ppreactions. ppTherefore, ppit ppis ppimportant ppto ppsubmit ppreports, ppeven ppif ppthere ppis
ppuncertainty ppabout ppthe ppcause–effect pprelationship. ppThe ppFDA ppprotects ppthe ppidentity ppof
ppthose ppwho ppvoluntarily ppreport ppadverse ppreactions.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp9 ppCognitive
ppLevel: ppApply
, Hospital ppclient ppNeeds: ppSafe ppand ppEffective ppCare ppEnvironment: ppSafety ppand ppInfection
ppControl
Integrated ppProcess: ppClinical ppProblem-solving ppProcess pp(Nursing ppProcess)
ppReference: ppp. pp7, ppBox pp1.1 ppMedWatch ppand ppReporting ppAdverse
ppEvents
3. A ppnursing ppattendant ppis ppassessing ppa pphospital ppclient ppand ppnotes ppthe pphospital ppclient
pphas ppdeveloped ppswelling ppof ppthe ppeyelids ppand pplips ppafter ppadministration ppof ppa
ppprescribed ppmedication. ppWhat ppdoes ppthe ppnursing ppattendant ppinterpret ppthis ppfinding ppto
ppspecifically ppindicate?
A) Mild ppallergic ppreaction
B) Anaphylactic ppshock
C) Angioedema
D) Drug ppidiosyncrasy
ACCURATE ppCHOICE:-C
Reasoning:->> ppAngioedema ppis ppa pptype ppof ppallergic ppdrug ppreaction ppmanifested ppby ppthe
ppcollection ppof ppfluid ppin ppthe ppsubcutaneous pptissues, ppmost ppcommonly ppaffecting ppthe
ppeyelids, pplips, ppmouth, ppand ppthroat. ppAllergic ppreactions ppcan ppbe ppmanifested ppby ppa ppwide
pprange ppof ppsigns ppand ppsymptoms ppsuch ppas ppitching, pprashes, ppand pphives. ppAnaphylactic
ppshock ppis ppa ppserious ppallergic ppreaction ppthat pprequires ppimmediate ppmedical ppattention.
ppDrug ppidiosyncrasy ppdescribes ppany ppunusual ppor ppabnormal ppreaction ppto ppa ppdrug, ppone ppthat
ppis ppdifferent ppfrom ppthe ppone ppnormally ppexpected.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp5 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppPhysiological ppIntegrity: ppReduction ppof ppRisk
ppPotential ppIntegrated ppProcess: ppClinical ppProblem-solving ppProcess pp(Nursing
ppProcess) ppReference: ppp. pp12, ppAllergic ppDrug ppReactions
4. The ppnursing ppattendant ppis pppreparing ppto ppteach ppa pphospital ppclient ppabout ppa ppnew ppdrug
ppwhich ppis ppin ppthe ppfourth ppphase ppof ppdevelopment. ppWhich ppactivity ppwill ppthe ppnursing
ppattendant ppexplain ppbest ppillustrates ppthis ppphase?
A) Primary pphealth ppcare ppproviders ppreport ppadverse ppeffects ppto ppFDA.
B) Healthy ppvolunteers ppare ppinvolved ppin ppthe pptest.
C) In ppvitro pptests ppare ppperformed ppusing pphuman ppcells.
D) The ppdrug ppis ppgiven ppto pp hospital ppclients ppwith ppthe ppdisease.
ACCURATE ppCHOICE:-A
, Reasoning:->> ppThe pppost ppmarketing ppsurveillance ppphase ppof ppdrug ppdevelopment
ppencourages ppprimary pphealth ppcare ppprofessionals ppto ppreport ppadverse ppeffects ppof ppdrugs ppto ppthe
ppFDA ppusing ppMedWatch. ppPhase pp1 ppof ppclinical pptesting ppinvolves pp20 ppto pp100 pphealthy
ppvolunteers. ppIn ppvitro pptesting ppof ppthe ppdrug ppon pphuman ppor ppanimal ppcells ppis ppdone ppin ppthe
pppre-FDA ppphase. ppIn ppPhase pp2 ppof ppclinical pptesting, ppthe ppdrug ppis ppgiven ppto pphospital
ppclients ppwith ppthe ppdisease ppfor ppwhich ppthe ppdrug ppis ppmanufactured.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp4 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppHealth ppPromotion ppand
ppMaintenance ppIntegrated ppProcess: ppTeaching/Learning
ppReference: ppp. pp7, ppConcept ppMastery ppAlert
5. A ppnursing ppattendant ppis ppassessing ppan ppexpectant pphospital ppclient ppwho ppadmits ppto
pphaving ppa ppcocaine ppaddiction. ppWhich ppcondition ppof ppthe ppbaby ppafter ppbirth
ppshould ppthe ppnursing ppattendant ppexplain ppand ppprepare ppthe pphospital ppclient ppfor?
A) Diabetes
B) Hypertension
C) Addiction ppto ppdrugs
D) CNS ppdefects
ACCURATE ppCHOICE:-C
Reasoning:->> ppThe ppnursing ppattendant ppinforms ppthe pphospital ppclient ppthat ppchildren
ppborn ppto p p mothers ppusing ppaddictive ppdrugs ppare ppoften ppborn ppwith ppan ppaddiction ppto
ppthe ppdrug. ppChildren ppborn ppto ppmothers ppwho ppare ppaddicted ppto ppcocaine ppare ppnot
ppknown ppto ppbe ppborn ppwith ppdiabetes, ppCNS ppdefects, ppor pphypertension.
Question pp p p Format: ppMultiple
ppChoice ppChapter: pp1
Learning ppObj: pp6 ppCognitive
ppLevel: ppApply
Hospital ppclient ppNeeds: ppHealth ppPromotion ppand
ppMaintenance ppIntegrated ppProcess: ppTeaching/Learning
Reference: ppp. pp11, ppDrug ppUse, ppPregnancy, ppand ppLactation
6. A pphospital ppclient pparrives ppat ppthe ppprimary pphealth ppcare ppclinic ppand ppreports pptaking
ppseveral pppills ppfor ppa ppheadacheppand ppsevere ppcough ppwithout pprelief. ppWhich ppadverse
ppeffect ppshould ppthe ppnursing ppattendant ppbe ppaware ppmay ppdevelop ppfrom ppthis
ppcombination?
A) Gastrointestinal ppbleeding
B) Breathing ppdifficulties
C) Liver ppdamage
D) Anaphylaxis
